Home > Drug Search >
  • company_query: Affymax
  •   > 
Drug Filter
Category:
chemistry (14) biology (5)
Status:
Approved (3) Withdrawn (1) NDA Filing (1) Phase Ⅱ (10) Phase Ⅰ (4)
Clinical Stage:
Pending (1) Active (12) Discontinued (2)
Bio-Type:
Vaccine (4) Recombinant hormone (1)
Indication:
Acute lymphoblastic leukaemia (ALL) (1) Anemia (1) Atopic dermatitis (1) Breast cancer (2) Chronic lymphocytic leukemia (CLL) (1) Cognitive disorders (1) Diabetic macular edema (1) Follicular B cell non-Hodgkin lymphoma (FL) (1) Germline BRCA mutated advanced ovarian cancer (1) Wet age-related macular degeneration (1) HIV infection (1) Cystinuria (1) Insomnia (1) Lung cancer (1) Major depressive disorder (MDD) (1) Multiple myeloma (MM) (1) Non small cell lung cancer (NSCLC) (1) Prostate cancer (2) Rheumatoid arthritis (RA) (1) Small lymphocytic lymphoma (SLL) (1) Solid tumours (1) Primary peritoneal cancer (1) Fallopian tube cancer (1) Epithelial ovarian cancer (1) Pain (1) Methicillin-resistant staphylococcus aureus infections (1) Hematological cancer (1) Allergic asthma (1) Liver cancer (1) Chronic fatigue syndrome (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top